no I don’t think so. AEI tested against a surrogate same as ZNO...

no I don’t think so. AEI tested against a surrogate same as ZNO

based on right now 1.2m a month bottling capacity will make $122m annual revenue (they stated previously 200k capacity was $1.7m revenue a month) They refer to a number of other material distribution deals in new parts of the globe so I am expecting a similar volume capacity to be announced for Europe and potentially Arab states. We know they are discussing Australia.

so HCT from current 26m market cap could within months be making $200m-$300m revenue.

that is very nice upside. The stuff can be pumped through buildings to kill the virus in the air. The balm will sell as many as they can make as will not have competition like sanitizers. They are applying for patent.

The virus test will lock in the rerate floor and from there this stock I think will be a monster. They actually have already tested successfully against other corona virus surrogates so as good as what ZNO have done already.